Common use of Compliance with Data Privacy Laws Clause in Contracts

Compliance with Data Privacy Laws. The Company is in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and since May 25, 2018, the Company has been and currently is in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The Company has in place, materially complies with, and takes appropriate steps reasonably designed to ensure compliance in all material respects with its policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents that it: (i) has not received written notice of any actual or potential liability, or actual or potential violation of, any of the Privacy Laws; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.

Appears in 5 contracts

Samples: Underwriting Agreement (Vera Therapeutics, Inc.), Sales Agreement (Vera Therapeutics, Inc.), Vera Therapeutics, Inc.

AutoNDA by SimpleDocs

Compliance with Data Privacy Laws. The Company is and the Subsidiaries are, and at all prior times were, in material compliance with all applicable state laws or statutes and federal data all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, relating to the use, processing, privacy and security laws of IT Systems and regulationsData and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, including without limitation HIPAA, and the Company and the Subsidiaries have taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, the Company has have been and currently is are in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The To ensure compliance with the Privacy Laws, the Company has and the Subsidiaries have in place, materially complies comply with, and takes take appropriate steps reasonably designed to ensure compliance in all material respects with its their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, processing, and analysis of Personal its IT Systems and Data (the “Policies”). The Company has at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in further certifies that neither it nor any Policy have been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents that itsubsidiary: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.

Appears in 4 contracts

Samples: Securities Purchase Agreement (ImmunityBio, Inc.), Securities Purchase Agreement (ImmunityBio, Inc.), Securities Purchase Agreement (ImmunityBio, Inc.)

Compliance with Data Privacy Laws. The Company is is, and at all prior times was, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAAand the Company has taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, the Company has have been and currently is are in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The To ensure compliance with the Privacy Laws, the Company has in place, materially complies comply with, and takes take appropriate steps reasonably designed to ensure compliance in all material respects with its their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents certifies that it: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.

Appears in 4 contracts

Samples: Underwriting Agreement (Landcadia Holdings II, Inc.), Underwriting Agreement (Landcadia Holdings II, Inc.), Underwriting Agreement (Landcadia Holdings IV, Inc.)

Compliance with Data Privacy Laws. The Company is and its Subsidiaries are in material compliance with all applicable state state, federal, and federal European Union data privacy and security laws and regulations, including without limitation HIPAA, and since May 25, 2018, to the Company has been and currently is in material compliance withextent applicable, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The Company has and its Subsidiaries have in place, and to the Company’s Knowledge, materially complies comply with, and takes appropriate steps reasonably designed to ensure compliance in all material respects with its their internal policies and procedures relating to governing data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has at all times and its Subsidiaries have, to the Company’s Knowledge, made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirementsPrivacy Laws, and none of such disclosures made or contained in any Policy have have, to the Company’s Knowledge, been inaccurate or in violation of any applicable laws and regulatory rules or requirements Privacy Laws in any material respect. The Neither the Company further represents that itnor any Subsidiary: (i) has not received written notice from a governmental or regulatory authority of any actual claims, investigations, inquiries or potential liability, or actual or potential violation of, any alleged violations of the applicable Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; or (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any applicable Privacy Law.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Outlook Therapeutics, Inc.), Securities Purchase Agreement (Outlook Therapeutics, Inc.)

Compliance with Data Privacy Laws. The Company is and its subsidiaries are, and for the past three (3) years have been, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation to the extent applicable, HIPAA, and since May 25, 2018, the Company has been and currently is in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The To the extent required by the Privacy Laws, the Company has and its subsidiaries have in place, materially complies comply in all material respects with, and takes take appropriate steps reasonably designed to ensure compliance in all material respects with its their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has and its subsidiaries have at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirementsPrivacy Laws, and none of such disclosures made or contained in any Policy have have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The During the past three (3) years, neither the Company further represents that itnor any subsidiary: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability by any regulatory or governmental authority under any Privacy Law.

Appears in 2 contracts

Samples: Oncternal Therapeutics, Inc., Oncternal Therapeutics, Inc.

Compliance with Data Privacy Laws. The Company is is, and at all prior times was, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and the Company has taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, the Company has been and currently is in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The To ensure compliance with the Privacy Laws, the Company has in place, materially complies with, and takes appropriate steps reasonably designed to ensure compliance in all material respects with its policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has has, except as would not reasonably be expected, individually or in the aggregate, to result in material liability to the Company, at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents certifies that it: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.

Appears in 2 contracts

Samples: Underwriting Agreement (IGM Biosciences, Inc.), Underwriting Agreement (IGM Biosciences, Inc.)

Compliance with Data Privacy Laws. The Company is and its subsidiaries are, and at all prior times were, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and the Company and its subsidiaries have taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, the Company has have been and currently is are in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”)) in all material respects. The To ensure compliance with the Privacy Laws, the Company has and its subsidiaries have in place, materially complies comply with, and takes take appropriate steps reasonably designed to ensure compliance in all material respects with its their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has and its subsidiaries have at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents certifies that itneither it nor any subsidiary: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.

Appears in 1 contract

Samples: Open Market Sale Agreement (Aclaris Therapeutics, Inc.)

Compliance with Data Privacy Laws. The Company is is, and at all prior times was, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and the Company has taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, the Company has been and currently is in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The To ensure compliance with the Privacy Laws, the Company has in place, materially complies with, and takes taken appropriate steps reasonably designed to ensure compliance in all material respects with its policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”)such Privacy Laws. The Company has at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents certifies that it: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential material violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.

Appears in 1 contract

Samples: Equity Distribution Agreement (Miromatrix Medical Inc.)

Compliance with Data Privacy Laws. The Company is is, and since May 25, 2018 has been, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and the Company has taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, the Company has been and currently is in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The To ensure compliance with the Privacy Laws, the Company has in place, materially complies with, and takes appropriate steps reasonably designed to ensure compliance in all material respects with its policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Since May 25, 2018, the Company has at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents certifies that it: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.

Appears in 1 contract

Samples: Purchase Agreement (Neuronetics, Inc.)

Compliance with Data Privacy Laws. The Company is and its subsidiaries are, and at all prior times were, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, CCPA, and since May 25, 2018, the Company has been and currently is in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The To ensure compliance with the Privacy Laws, the Company has in place, materially complies with, and takes appropriate steps reasonably designed to ensure compliance in all material respects with its their policies and procedures relating to data privacy and security and the collection, storage, use, processing, disclosure, handling, and analysis of Personal Data and Confidential Data (the “Policies”). The Company has at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none None of such the Company’s disclosures made or contained in any Policy have been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents certifies that itneither it nor any subsidiary: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.. (aaa)

Appears in 1 contract

Samples: SAB Biotherapeutics, Inc.

AutoNDA by SimpleDocs

Compliance with Data Privacy Laws. The Company is is, and at all prior times since January 1, 2018, was, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and the Company has taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, the Company has have been and currently is are in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The To ensure compliance with the Privacy Laws, the Company has in place, materially complies with, and takes appropriate steps reasonably designed to ensure compliance in all material respects with its policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has at all times since January 1, 2018, made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents certifies that it: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or and (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any material obligation or liability under any Privacy Law.

Appears in 1 contract

Samples: Underwriting Agreement (Aerovate Therapeutics, Inc.)

Compliance with Data Privacy Laws. The Company is is, and at all prior times was, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAAand the Company has taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, the Company has have been and currently is are in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union GDPR (collectively, the “Privacy Laws”). The To ensure compliance with the Privacy Laws, the Company has in place, materially complies with, and takes appropriate steps reasonably designed to ensure compliance in all material respects with its policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents certifies that it: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.

Appears in 1 contract

Samples: Underwriting Agreement (Empowerment & Inclusion Capital I Corp.)

Compliance with Data Privacy Laws. The Company is and its Subsidiaries are, and at all prior times were, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and the Company and its Subsidiaries have taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, the Company has have been and currently is are in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”), in all material respects. The To ensure compliance with the Privacy Laws, the Company has and its Subsidiaries have in place, materially complies comply with, and takes take appropriate steps reasonably designed to ensure compliance in all material respects with its their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has and its subsidiaries have at all times made all relevant disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further represents certifies that itneither it nor any subsidiary: (i) has not received written notice of any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws; (ii) is not currently conducting or paying for, in whole or in part, any material investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.

Appears in 1 contract

Samples: Chiasma, Inc

Compliance with Data Privacy Laws. The Company is and its subsidiaries are, and at all prior times were, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and since May 25, 2018, the Company has been and currently is in material compliance with, its subsidiaries have taken commercially reasonable steps designed to comply with the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union (collectively, the “Privacy Laws”). The Company has and its subsidiaries have in place, materially complies comply with, and takes appropriate take commercially reasonable steps reasonably designed to ensure compliance comply, in all material respects respects, with its their published policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has and its subsidiaries have at all times made all relevant disclosures to users or customers individuals required by applicable laws Privacy Laws and regulatory rules or requirements, and none of no such disclosures made or contained in any Policy have have, to the knowledge of the Company, been inaccurate or in material violation of any applicable laws and regulatory rules or requirements in Privacy Law. To the Company’s knowledge, neither it nor any material respect. The Company further represents that itsubsidiary: (i) has not received written notice of any actual material Privacy Law violation, and has no knowledge of any event or potential liability, or actual or potential violation of, condition that would reasonably be expected to result in any of the Privacy Lawssuch notice; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy LawLaw violation; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any obligation or liability under any Privacy Law.

Appears in 1 contract

Samples: Open Market Sale (aTYR PHARMA INC)

Compliance with Data Privacy Laws. The Company is and its subsidiaries are, to the extent applicable to the Company’s operations, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and since May 25, 2018, the Company has been and currently is its subsidiaries have defined a compliance program to be implemented in material compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) and all applicable national data protection laws in effect in the United Kingdom and the member states of the European Union order to comply with GDPR (collectively, the “Privacy Laws”). The Company has and its subsidiaries have in place, materially complies comply with, and takes take appropriate steps reasonably designed to ensure compliance in all material respects with its their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company has and its subsidiaries have at all times made all relevant material disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Neither the Company further represents that itnor any of its subsidiaries: (i) has not received written notice of alleging any actual or potential liabilityliability under or relating to, or actual or potential violation of, any of the Privacy Laws; (ii) is not currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is not a party to any order, decree, or agreement with a governmental authority that imposes any material obligation or liability under any Privacy Law.

Appears in 1 contract

Samples: Underwriting Agreement (Nanobiotix S.A.)

Time is Money Join Law Insider Premium to draft better contracts faster.